::INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES::

CODEN : IAJPBB
issn 2349-7750

News Updates Latest Volumes: COSMOS IMPACT FACTOR (2018)- 4.153, GLOBAL IMPACT FACTOR(2014) - 0.384, (2015) - 0.437, Indo American Journal of Pharmaceutical Sciences,

ResearcherID - CLICK HERE Scientific Journal Impact Factor (SJIF-2020) - CLICK HERE

TITLE:

STUDY TO DETERMINE THE INCIDENCE OF ONYCHOMYCOSIS IN DIABETIC PATIENTS

AUTHORS:

Dr Ifrah Jabbar, Dr Shanza Naeem, Dr Fazal Abbas Haider

ABSTRACT:

Aim: To determine the incidence of onychomycosis in diabetes and its relationship to age, gender, diabetes and control. Place and Duration: In the dermatology department of Jinnah Hospital Lahore for one-year duration from March 2019 to February 2020. Patients and methods: This descriptive study included 262 patients with type 2 diabetes. All patients were examined by a dermatologist, and patients with clinical suspicions were referred for laboratory examination, i.e. smear and culture. Confirmed cases of onychomycosis were treated with terbinafine 250 mg / day for four months. Patients were clinically observed monthly and data were recorded. Direct smear and nail culture were taken at the end of the treatment protocol. Results: 262 diabetic patients (123 men and 139 women) were examined. The mean age and duration of diabetes was 59.12 ± 10.96 years and 7.24 ± 12.8 years, respectively. Nail fungus has been clinically diagnosed in 18 patients (6.9%), and a culture study was performed in only 10 patients (3.8%). 70% of cases of onychomycosis are men, and 60% were over 60 years old. There was no significant relationship between the incidence of onychomycosis and the duration of diabetes, but onychomycosis is more common in patients with poor diabetes control. Conclusion: The incidence of onychomycosis in patients with type 2 diabetes is 3.8% and is significantly associated with poor diabetes control. Key words: diabetes mellitus, onychomycosis.